Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 30% ± 17% | |
lung | 8 studies | 18% ± 3% | |
eye | 6 studies | 23% ± 9% | |
adipose | 4 studies | 20% ± 3% | |
peripheral blood | 3 studies | 24% ± 6% | |
bone marrow | 3 studies | 19% ± 1% | |
intestine | 3 studies | 21% ± 7% | |
liver | 3 studies | 37% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5858.50 | 1445 / 1445 | 100% | 73.27 | 183 / 183 |
intestine | 100% | 6198.81 | 966 / 966 | 100% | 57.24 | 527 / 527 |
prostate | 100% | 5710.98 | 245 / 245 | 100% | 59.11 | 502 / 502 |
uterus | 100% | 6979.55 | 170 / 170 | 100% | 62.66 | 459 / 459 |
brain | 100% | 4875.50 | 2641 / 2642 | 100% | 72.67 | 705 / 705 |
breast | 100% | 5432.81 | 459 / 459 | 100% | 81.64 | 1117 / 1118 |
bladder | 100% | 6679.48 | 21 / 21 | 100% | 55.14 | 503 / 504 |
lung | 100% | 5182.00 | 578 / 578 | 100% | 61.42 | 1151 / 1155 |
stomach | 100% | 4218.64 | 359 / 359 | 100% | 59.45 | 285 / 286 |
ovary | 100% | 6911.80 | 180 / 180 | 100% | 49.62 | 428 / 430 |
thymus | 100% | 5412.16 | 653 / 653 | 100% | 59.30 | 602 / 605 |
skin | 100% | 6068.95 | 1808 / 1809 | 99% | 78.96 | 469 / 472 |
adrenal gland | 100% | 5603.56 | 258 / 258 | 99% | 47.16 | 227 / 230 |
pancreas | 99% | 2693.70 | 325 / 328 | 99% | 48.92 | 177 / 178 |
kidney | 100% | 3091.35 | 89 / 89 | 98% | 48.99 | 882 / 901 |
liver | 100% | 2489.27 | 226 / 226 | 93% | 29.77 | 379 / 406 |
adipose | 100% | 5809.58 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6101.80 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 64.90 | 29 / 29 |
muscle | 100% | 4829.42 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5699.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 65.13 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 26.03 | 1 / 1 |
heart | 99% | 3408.92 | 852 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 28.74 | 74 / 80 |
peripheral blood | 78% | 3410.85 | 723 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0006974 | Biological process | DNA damage response |
GO_1905213 | Biological process | negative regulation of mitotic chromosome condensation |
GO_0043687 | Biological process | post-translational protein modification |
GO_0006338 | Biological process | chromatin remodeling |
GO_0045945 | Biological process | positive regulation of transcription by RNA polymerase III |
GO_0045943 | Biological process | positive regulation of transcription by RNA polymerase I |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0043596 | Cellular component | nuclear replication fork |
GO_0005730 | Cellular component | nucleolus |
GO_0110016 | Cellular component | B-WICH complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090535 | Cellular component | WICH complex |
GO_0005721 | Cellular component | pericentric heterochromatin |
GO_0000793 | Cellular component | condensed chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0004715 | Molecular function | non-membrane spanning protein tyrosine kinase activity |
GO_0042393 | Molecular function | histone binding |
GO_0140801 | Molecular function | histone H2AXY142 kinase activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
GO_0035173 | Molecular function | histone kinase activity |
Gene name | BAZ1B |
Protein name | Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2) |
Synonyms | WBSCR9 WSTF WBSC10 WBSCR10 |
Description | FUNCTION: Atypical tyrosine-protein kinase that plays a central role in chromatin remodeling and acts as a transcription regulator . Involved in DNA damage response by phosphorylating 'Tyr-142' of histone H2AX (H2AXY142ph) . H2AXY142ph plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress . Regulatory subunit of the ATP-dependent WICH-1 and WICH-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair . Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template . The WICH-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the WICH-5 ISWI chromatin remodeling complex . The WICH-5 ISWI chromatin-remodeling complex regulates the transcription of various genes, has a role in RNA polymerase I transcription (By similarity). Within the B-WICH complex has a role in RNA polymerase III transcription . Mediates the recruitment of the WICH-5 ISWI chromatin remodeling complex to replication foci during DNA replication . . |
Accessions | ENST00000339594.9 [Q9UIG0-1] Q9UIG0 ENST00000404251.1 [Q9UIG0-1] |